Amino Collective

"Portal Biotech’s technology offers unprecedented capabilities in protein identification and characterisation, providing unmatched detail on protein structure and modifications at the single-molecule level on accessible desktop instruments that bring this state-of-the-art characterisation to any lab. These powerful advances are essential for accelerating drug discovery and enhancing diagnostic precision, positioning Portal Biotech as the frontrunner in the race to unlock the full potential of protein sequencing."

"At ExpressionEdits, we’re revolutionizing gene expression by putting introns back where they belong, resulting in significant improvements in production"

"We’re excited to bring Inga of Molten on our journey. From day one, it was clear to us that she shared our vision of care enablement, a thesis Inga and Molten have had for years. I’m deeply grateful for the special crew we have at Anima. This is a passion project – we’re building what we wish we had as doctors and patients. No one is here just to do a job. We all serve a greater purpose – and that’s why ultimately we’ll continue to move mountains."

"Clinical trials are the biggest bottleneck to improving human health. We deliver clinical trials three times faster than the industry standard, working with biotech pioneers to get new treatments to patients more quickly."

"Traditional clinical research companies are dinosaurs. Taking part in a COVID vaccine trial was like stepping into a time machine. This was one of the best funded trials in history but research was done on pen and paper and participants had to go into hospital at the height of the pandemic to fill out forms. We founded Lindus Health to make it easier for patients to participate in research, and accelerate the development of new treatments."